Company Profile

ArunA Biomedical Inc (AKA: ArunA Bio)
Profile last edited on: 8/30/2022      CAGE: 452D5      UEI: ND2FX8DQ2K33

Business Identifier: Neural progenitor cell growth
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

184 Collins Industrial Boulevard Suite A
Athens, GA 30601
   (678) 879-5264
Location: Single
Congr. District: 09
County: Clarke

Public Profile

ArunA Bio is organized around neurotherapeutic development with the firm's neural exosome therapeutic platform anchored in the capacity of the firm's proprietary neural exosomes to cross the blood brain barrier enables drugs and drug combinations to naturally target cells and treat patients with a range of neurological disorders. Aruna's being ale reliably manufacture exosomes at scale addresses one of the biggest challenges in the exosome field today The firm offers neuroscience products, including STEMEZ hNP1 neural progenitor cell expansion kits, which are used for various research applications, such as studies of neurotoxicity, neurogenesis, electrophysiology, and neurotransmitter and receptor functions; and STEMEZ hN2 that are normal human neurons grown as an adherent monolayer cell culture that is used in research, including disease studies, drug discovery, neurotoxicity, imaging, and high-throughput assays. The company also provides viPS Vector Kit for reprogramming somatic cells to generate induced pluripotent stem cells; and human stem cell systems that are used for applications and assays, including cellular model studies, high content screening, developmental studies, RNAi studies, and genetic manipulation. In addition, Aruna offers drug discovery and development services; and testing and assay services serving pharmaceutical companies, as well as academic researchers in brain and spinal cord research.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Stephen From -- Chief Executive Officer

  Harold "Bud" Ingalls -- President and Chief Executive Officer

  Steven L Stice -- Co-Founder, CEO and Chief Scientific Officer

  Tracey Worhtington-Stice -- Co-Founder, Executive Vice President, Manufacturing and Process Development

  Lauren Arnold

  Emily W Baker

  Jamie M Chilton -- Research Scientist, iPSC Team Leader

  David W Machacek

  Anirban Majumder

  Jim Stice

  Robin L Webb